Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

Diabetes and cardiovascular disease. The Framingham study

1979 • 4,047 citations

Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease

1971 • 2,055 citations

Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up Experience

1961 • 1,758 citations

Dietary influences on serum lipids and lipoproteins.

1990 • 1,065 citations

MOBILE CORONARY CARE

1974 • 856 citations

The discovery and development of HMG-CoA reductase inhibitors.

1992 • 829 citations

Diabetes as an atherogenic factor

1984 • 287 citations

Role of Cardiovascular Risk Factors in Prevention and Treatment of Macrovascular Disease in Diabetes

1989 • 233 citations

Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.

1985 • 210 citations

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors

1993 • 176 citations

Effect of Proteinuria on Mortality in NIDDM

1988 • 169 citations

Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

1985 • 140 citations

WHY DOES PLASMA LOW DENSITY LIPOPROTEIN CONCENTRATION IN ADULTS INCREASE WITH AGE?

1984 • 114 citations

Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays

1991 • 98 citations

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia

1990 • 87 citations

Effect of proteinuria on mortality in NIDDM

1988 • 77 citations

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia

1990 • 77 citations

Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)

1989 • 43 citations

Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study)

1992 • 27 citations

Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjects

1988 • 24 citations

Characteristics of binding between reagent-strip indicators and urinary proteins.

1977 • 21 citations

Effects of CS-514, a New Inhibitor of HMG CoA Reductase, on Plasma Lipids, Lipoproteins and Apoproteins in Patients with Primary Hypercholesterolemia

1986 • 17 citations

Characteristics of binding between reagent-strip indicators and urinary proteins.

1977 • 17 citations

CS-514 Suppresses Plasma Triglyceride in Hypertriglyceridemic Subjects Without Modifying a Lipoprotein Structural Model

1987 • 11 citations

Efficacy and tolerability of lovastatin in elderly hypercholesterolemic patients.

1992 • 4 citations